Home > Healthcare > Medical Devices > Diagnostic Devices > home care testing market
Get a free sample of Home Care Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Home Care Testing Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Based on product type, the market is categorized into strip, cassette, test panel, midstream, dip card, and other product types. The strip segment dominated the market, with a revenue share of around 25.8% in 2023.
Based on test type, the home care testing market is categorized into infectious disease, diabetes & glucose, HIV, pregnancy, cholesterol & triglycerides, urinary tract infection, and other test types. The infectious disease segment is anticipated to witness highest growth with USD 5.2 billion in 2032.
Based on sample, the home care testing market is categorized into blood, urine, saliva, and other samples. The blood segment dominated the market, with a revenue share of 40.7% in 2023.
Based on distribution channel, the home care testing market is categorized into retail pharmacies, hospital pharmacies, online pharmacies and other distribution channel. The retail pharmacies segment dominated the market, with a revenue share of around 39.1% in 2023.
North America home care testing market accounted for USD 4.9 billion revenue in 2023 and is predicted to witness substantial market growth over the analysis timeline.
U.S. home care testing market holds a dominant position with the market share of 93.8% in 2023.
Germany home care testing market is expected to grow significantly during the forecast period.
China home care testing market is anticipated to witness a high growth rate from 2024-2032, due to several factors.
Chembio Diagnostics, Inc, F. Hoffmann-La Roche Ltd., LifeScan IP Holdings, LLC, MP BIOMEDICALS, Nova Biomedical, OraSure Technologies, Inc., Quidel Corp, SA Scientific Ltd, Siemens Healthcare GmbH, and Sterilab Services among others.
North America home care testing market size was USD 4.9 billion in 2023 and is predicted to witness substantial market growth through 2032, driven by the increasing incidence of chronic diseases, such as diabetes, hypertension, and cardiovascular conditions.
Home care testing market size was valued at USD 10.9 billion in 2023 and is estimated to grow at 6.8% CAGR from 2024 to 2032, driven by the rising prevalence of chronic diseases.
The strip segment held a 25.8% revenue share in 2023 and will grow rapidly through 2032, owing to its versatility.